Symposium 46 I I II II III III / narrow QRS tachycardia 139/ P V1 HIS 5 6 HIS 3 4 HIS 1 2 CS 9 10 CS 7 8 CS 5 6 CS 3 4 CS 1 2 RV 3 4 RV

Size: px
Start display at page:

Download "Symposium 46 I I II II III III 1 12 54/ narrow QRS tachycardia 139/ P V1 HIS 5 6 HIS 3 4 HIS 1 2 CS 9 10 CS 7 8 CS 5 6 CS 3 4 CS 1 2 RV 3 4 RV 1 2 100"

Transcription

1 Symposium 46 Inappropriate Sinus Tachycardia1 inappropriate sinus tachycardiaistp 100/ 1 IST 2 IST IST atrio ventricular nodal reentrant tachycardiavnrt IST / 1 narrow QRS 139/aVFP1 His jump up 2 530msec narrow QRS 3 His VNRT VNRT 2 120/ 89/ 4 175/ 4 4CIST 2.5mg 1 / Tsugiyoshi Yamazaki, et al. case of inappropriate sinus tachycardia after atrio ventricular nodal reentrant tachycardia ablation 952

2 Symposium 46 I I II II III III / narrow QRS tachycardia 139/ P V1 HIS 5 6 HIS 3 4 HIS 1 2 CS 9 10 CS 7 8 CS 5 6 CS 3 4 CS 1 2 RV 3 4 RV mm/sec 2 Jump up 460msec 250msec Jump up 73/ / 5C 67/ 114/ 6 953

3 Symposium 46 V1 HIS 5 6 HIS 3 4 HIS 1 2 CS 9 10 CS 7 8 CS 5 6 CS 3 4 CS 1 2 RV 3 4 RV mm/sec 3 VNRT 300 msec530 msecvnrt 6 2 standard deviation of all normal sinus RR intervals over 24 hsdnn 78 msec 7 percentage of successive normal sinus RR intervals 50 ms RR IST IST 90 IST 3 IST 64 VNR T posterolateral accessory pathway Hz 2 RR SDNN RR 50 SDNN msec 4 954

4 Symposium Sinus tachycardia, 175 bpm 25.0 mm/sec C /175/ C 955

5 Symposium couplet 1 9:25: C Sinus tachycardia, 136 bpm 25.0 mm/sec 5 2.5mg C 78.0 msecsdnn RR 50 RR RR msec

6 Symposium IST IST 50 6 If 7 5 mg ng/ml mg ng/ml 15.8 VNR T IST 957

7 Symposium 46 7 RR SDNN RR 50 SDNN RR 50 1 Olshansky, et al. Inappropriate sinus tachycardia. J m Coll Cardiol 2013;61: Kocovic DZ, et al. lterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia. Circulation 1993;88: Olgin JE. Sinus tachycardia and sinus node reentry. In Zipes DP, Jalife J. Cardiac Electrophysiology: From Cell to edside 2000: Umetani K,et al. Twenty four hour time domain heart rate variability and heart rate : Relations to age and gender over nine decades. J m Coll Cardiol 1998;31: Ewing DJ, et al. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. r Heart J 1984;52: Shinbane JS, et al. Long term follow up after radiofrequency sinus node modification for inappropriate sinus tachycardia. J m Coll Cardiol 1997;29: Sisti D, et al. case of inappropriate sinus tachycardia after atrio ventricular nodal reentrant tachycardia cr yoablation successfully treated by ivabradine. Europace 2010;12:

3 m/sec 8.35 39.06 3.22 2.15 13.72 52.78 15.00 2.12 2.69 12.62 27.62 3 m/ 772 79 68 263 410 1,182 3 m/sec 3.87 0.63 8.00 3.12 1.38 12.50 12.50 2.00 2.50 1.00 5.50 5.50 m/ 105 122 20 247 247 3 m/sec 0.23

More information

”RŠœ15-3 #50 ‘¬’X 4“Z+

”RŠœ15-3 #50 ‘¬’X 4“Z+ 15 3 45 57 2000 QOL 1950 Cardiac Arrhythmia Suppression Trial 10 WPW 1 10 1990 1996 409-3898 1110 2000 5 23 2000 6 2 4 46 2 2 3 2 1 1 3 3 40 1 10 6 12 Cardiac Arrhythmia Suppression Trial CAST 4 1 3 CAST

More information

C/NC : committed/noncommitted

C/NC : committed/noncommitted C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a

More information

埼玉29.indb

埼玉29.indb 16 Symposium 29 WPW 1 1 1 1 1 78 PSVT 4 cibenzoline 200mg, verapamil 80mg 2 OMI #7 100 X 51% HbA 1c 5.9% 12 1A 55/ V 1,2 Q 1B 116/ narrow QRS tachycardia av F V 1 P LVEDD/LVESD 55/38mm EF 58 PSVT RV His

More information

I? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................

More information

20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472

More information

- 2 -

- 2 - - 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -

More information

2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1

2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1 1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4

More information

1 (1) (2)

1 (1) (2) 1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)

More information

高周波カテーテルアブレーションで根治した薬剤抵抗性潜在性右前中隔副伝導路の10カ月乳児例 第28巻02号0136頁

高周波カテーテルアブレーションで根治した薬剤抵抗性潜在性右前中隔副伝導路の10カ月乳児例 第28巻02号0136頁 症例報告 PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 28 NO. 2 (136 142) 高周波カテーテルアブレーションで根治した薬剤抵抗性潜在性右前中隔副伝導路の 10 カ月乳児例 藤田修平 1), 中村太地 1), 臼田和生 2) 3), 渡辺一洋 市田蕗子 3) 1), 畑崎喜芳 富山県立中央病院小児科 1), 富山県立中央病院内科循環器 2),

More information

1315 (15)

1315 (15) (14) 1315 (15) 1316 (16) 1317 (17) 1318 (18) 1319 (19) 1320 (20) 1321 (21) 1322 quinidine, disopyramide, and procainamide in isolated atrial myocytes : Mediation by 2) Inoue H, et al: Effects of pentisomide

More information

1) Beazell J, Tan K, Criley J, Schulman J:The electrosurgical production of heart block without thoracotomy (abstr). Clin Res 24: 137, 1976 2) Vedel J, Frank R, Fontaine G, Fournial JF, Grosgogeat Y:Bloc

More information

1) Stallmann, F. W., and Pipberger, H. V.: Automatic recognition of electrocardiographic waves by digital computer. Circulation Research, 9, 1138, 1961. 2) Whitemen, J. R., Gorman, P. A., Calataynd, J.

More information

1 2

1 2 1 2 4 3 5 6 8 7 9 10 12 11 0120-889-376 r 14 13 16 15 0120-0889-24 17 18 19 0120-8740-16 20 22 21 24 23 26 25 28 27 30 29 32 31 34 33 36 35 38 37 40 39 42 41 44 43 46 45 48 47 50 49 52 51 54 53 56 55 58

More information

3 5 6 7 7 8 9 5 7 9 4 5 6 6 7 8 8 8 9 9 3 3 3 3 8 46 4 49 57 43 65 6 7 7 948 97 974 98 99 993 996 998 999 999 4 749 7 77 44 77 55 3 36 5 5 4 48 7 a s d f g h a s d f g h a s d f g h a s d f g h j 83 83

More information

21-07_後藤論文.smd

21-07_後藤論文.smd 2015; 21: 5866 Yoichi Goto: Current status and future perspective of cardiac rehabilitation in Japan. J Jpn Coron Assoc 2015; 21: 5866 I 1 1 3 1 2 3 QOL 2 Fig. 1 1 196070 AMI AMI 1980 AMI CABG comprehensive

More information

PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 24 NO. 5 ( ) Electrophysiological Studies and Radiofrequency Catheter Ablation before Total Cavo-p

PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 24 NO. 5 ( ) Electrophysiological Studies and Radiofrequency Catheter Ablation before Total Cavo-p PEDIATRIC CARDIOLOGY and CARDIAC SURGERY VOL. 24 NO. 5 (620 627) Electrophysiological Studies and Radiofrequency Catheter Ablation before Total Cavo-pulmonary Connection in Patients with Complex Congenital

More information

Ventricular tachycardia recurrence as an electrical storm three years after radiofrequency ablation in a non ischemic cardiomyopathy and apical aneury

Ventricular tachycardia recurrence as an electrical storm three years after radiofrequency ablation in a non ischemic cardiomyopathy and apical aneury Ventricular tachycardia recurrence as an electrical storm three years after radiofrequency ablation in a non ischemic cardiomyopathy and apical aneurysm case Key words 心臓 Vol.43 SUPPL.3 2011 169 図1 初回入院時VT

More information

3 4 6 7 8 9 10 12 14 2 3

3 4 6 7 8 9 10 12 14 2 3 3 4 6 7 8 9 10 12 14 2 3 POINT 4 5 3053 1323 4 7 6 1 1 4 7 Yamada N. et al : Int J Cardiol. 98, 409-411, 2005 6 7 POINT 0 20 40 60 80 100 60 80 Ota M. et al: Heart Vessels. 17, 7-11,2002 40 60 20 50 15

More information

ONO L 0.03mg/kg/min 1min 0.01mg/kg/min 10min M 0.03mg/kg/min 1min 0.02mg/kg/min 10min H 0.06mg/kg/min 1min 0.04mg/kg/min 10min 3 1) LSD p=0.000

ONO L 0.03mg/kg/min 1min 0.01mg/kg/min 10min M 0.03mg/kg/min 1min 0.02mg/kg/min 10min H 0.06mg/kg/min 1min 0.04mg/kg/min 10min 3 1) LSD p=0.000 ONO-1101 7 L 0.03mg/kg/min1min0.01mg/kg/min10minM 0.03mg/kg/min1min0.02mg/kg/min 10minH 0.06mg/kg/min1min0.04mg/kg/min10min 3 1) LSD p=0.0001) 30 2) FACCFSVcfc LVESWS EDA DT MH LSD p

More information

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2) (1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46

More information

Exif Viewer, DPOF Editor 使用説明書

Exif Viewer, DPOF Editor 使用説明書 Exif Viewer DP Editor 2 3 I 4 II III 5 I 6 I 7 I 8 I 9 I 10 I 11 I 12 I 13 I 14 I 15 I 16 I 17 I 18 I 19 I 20 I 21 I 22 I 23 I 24 25 I 26 I 27 I 28 I 29 I Windows 30 I 31 I 32 I 33 I 34 35 II II 36 II

More information

i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii

More information

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 1000101_ 1000102_ 1000103_ 1000301_ 1000302_ 1000303_ 1000401_ 1000402_ 1000403_ 1000701_ 1000702_ 1000703_ 1000801_ 1000802_ 1000803_ 1000901_ 1000902_ 1000903_ 1001001_ 1001002_ 1001003_ 1001101_ 1001102_

More information

THE EFFECTS OF ABDOMINAL BREATHING ON AUTONOMIC NERVOUS FUNCTION IN WOMEN \ THE RELATIONSHIP AMONG INDIVIDUAL DIFFERENCES IN AUTONOMIC NERVOUS SYSTEM

THE EFFECTS OF ABDOMINAL BREATHING ON AUTONOMIC NERVOUS FUNCTION IN WOMEN \ THE RELATIONSHIP AMONG INDIVIDUAL DIFFERENCES IN AUTONOMIC NERVOUS SYSTEM THE EFFECTS OF ABDOMINAL BREATHING ON AUTONOMIC NERVOUS FUNCTION IN WOMEN \ THE RELATIONSHIP AMONG INDIVIDUAL DIFFERENCES IN AUTONOMIC NERVOUS SYSTEM ACTIVITY IN A SUPINE POSITION AT REST \ KASUMI SAKAKI

More information

074-079 14池田 45-3●3/田.indd

074-079 14池田 45-3●3/田.indd 74 心 臓 Vol.45 SUPPL.3(2013) 第 25 回 臨 床 不 整 脈 研 究 会 下 大 静 脈 半 奇 静 脈 結 合 に 左 上 大 静 脈 遺 残 を 合 併 した 左 脚 ブロック 型 wide QRS tachycardiaの 1 例 池 田 悦 子 平 松 茂 樹 山 根 弘 基 萩 倉 新 菊 田 雄 悦 佐 藤 克 政 谷 口 将 人 後 藤 賢 治 谷 口 学

More information

Microsoft Word - 表紙資料2-4

Microsoft Word - 表紙資料2-4 (1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)

More information

Platanus Vol.2

Platanus Vol.2 Platanus vol. 8-1 - - 2 - - 3 - Adrenalin (ng/ml) 0.12 0.08 0.04 0.00 Adrenalin (ng/ml) 0.12 0.08 0.04 0.00 18 20 22 24 2 4 6 8 10 12 14 16 Time of Day (hour) - 4 - Noradrenalin (ng/ml) 4.00 3.00 2.00

More information

1 10 1113 14 1516 1719 20 21 22 2324 25 2627 i 2829 30 31 32 33 3437 38 3941 42 4344 4547 48 4950 5152 53 5455 ii 56 5758 59 6061 iii 1 2 3 4 5 6 7 8 9 10 PFI 30 20 10 PFI 11 12 13 14 15 10 11 16 (1) 17

More information

098青沼班DGfinal修正0506.indd

098青沼班DGfinal修正0506.indd 1 2011 Brugada QT 2005 2006 2007 Brugada Brugada 20 QT 70 2007 Brugada ICD ICD 5 2 QT Brugada 2012 QT QT QT Brugada Brugada 5 AHA/ACC ESC I II III A B C I II IIa IIb III A B C QT long QT syndrome LQTS

More information

22...J.e.A.u.Q01-07_.O.t

22...J.e.A.u.Q01-07_.O.t 113:00~14:00 The Value of Electrogram Analyses in Defining Arrhythmia Mechanisms-Implications for Catheter Ablation Melvin M. Scheinman University of California San Francisco, USA 1 112:00~13:00 Next Generation

More information

サービス付き高齢者向け住宅賠償責任保険.indd

サービス付き高齢者向け住宅賠償責任保険.indd 1 2 1 CASE 1 1 2 CASE 2 CASE 3 CASE 4 3 CASE 5 4 3 4 5 6 2 CASE 1 CASE 2 CASE 3 7 8 3 9 10 CASE 1 CASE 2 CASE 3 CASE 4 11 12 13 14 1 1 2 FAX:03-3375-8470 2 3 3 4 4 3 15 16 FAX:03-3375-8470 1 2 0570-022808

More information

2004 12 16 2 1 3 2 5 2.1............... 5 2.2........... 14 2.3........................... 17 3 22 3.1.................. 22 3.2......................... 22 3.3........................ 25 3.4........................

More information

Pacing Rhythm NO.2

Pacing Rhythm NO.2 No.2 1 2 3 4 5 6 % %!!!!!! 7 8 9 10 11 12 13 14 15 16 17 Ð Ð Ð Ð Ð Ð Ð Ð 18 19 Circulation J Am Coll Cardiol. J Am Coll Cardiol. Circulation. Circulation. J Cardiovasc Electrophysiol. Circulation. Circulation.

More information

(個別のテーマ) 薬剤に関連した医療事故

(個別のテーマ) 薬剤に関連した医療事故 - 67 - III - 68 - - 69 - III - 70 - - 71 - III - 72 - - 73 - III - 74 - - 75 - III - 76 - - 77 - III - 78 - - 79 - III - 80 - - 81 - III - 82 - - 83 - III - 84 - - 85 - - 86 - III - 87 - III - 88 - - 89

More information

(個別のテーマ) 放射線検査に関連した医療事故

(個別のテーマ) 放射線検査に関連した医療事故 - 131 - III - 132 - - 133 - III - 134 - - 135 - III - 136 - - 137 - III - 138 - - 139 - III - 140 - - 141 - III - 142 - - 143 - III - 144 - - 145 - III - 146 - - 147 - III - 148 - - 149 - III - 150 - -

More information

EV200R I II III 1 2 3 4 5 6 7 8 9 10 1 2 3 11 4 5 12 6 13 1 2 14 3 4 15 5 16 1 2 17 3 18 4 5 19 6 20 21 22 123 456 123 456 23 1 2 24 3 4 25 5 3 26 4 5 6 27 7 8 9 28 29 30 31 32 1 2 33 3 4 34 1 35 2 1

More information

訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書

訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書 1... 1 2... 3 I... 3 II... 3 1.... 3 2....15 3....17 4....19 5....25 6....34 7....38 8....48 9....58 III...70 3...73 I...73 1....73 2....82 II...98 4...99 1....99 2....104 3....106 4....108 5.... 110 6....

More information

I

I I II 1 2 3 4 5 6 7 8 9 10 11 Rp.1) 50mg 3 3 14 Rp.2) 2.5mg 2 14 Rp.1) 2.5mg 3 2 2:1 14 Rp.) 15g 1 3 28 Rp.2) 50 600mg 1 2 28 12 Rp.1) CR 20mg 1 1 1 14 Rp.2) R 200 1 2 14 Rp.3) 3 1 3 14 Rp.1) 2.5mg 0.4

More information

パナソニック技報

パナソニック技報 Liquid Crystal Display Technology for Realizing Contrast Ratio of 1 million to 1 Katsuhiro Kikuchi LCDLiquid Crystal Display IPSIn-Plane Switching-LCD 2100:1 IPS-LCDIPS-LCD50 20:1 Realization of Liquid

More information

Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth

Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth and Foot Breadth Akiko Yamamoto Fukuoka Women's University,

More information

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ( ) 24 25 26 27 28 29 30 ( ) ( ) ( ) 31 32 ( ) ( ) 33 34 35 36 37 38 39 40 41 42 43 44 ) i ii i ii 45 46 47 2 48 49 50 51 52 53 54 55 56 57 58

More information

23 15961615 1659 1657 14 1701 1711 1715 11 15 22 15 35 18 22 35 23 17 17 106 1.25 21 27 12 17 420,845 23 32 58.7 32 17 11.4 71.3 17.3 32 13.3 66.4 20.3 17 10,657 k 23 20 12 17 23 17 490,708 420,845 23

More information

untitled

untitled i ii (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (2) (3) (1) (2) (3) (1) (1) (1) (1) (2) (1) (3) (1) (2) (1) (3) (1) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3)

More information

平成18年度「商品先物取引に関する実態調査」報告書

平成18年度「商品先物取引に関する実態調査」報告書 ... 1.... 5-1.... 6-2.... 9-3.... 10-4.... 12-5.... 13-6.... 15-7.... 16-8.... 17-9.... 20-10.... 22-11.... 24-12.... 27-13... 29-14.... 32-15... 37-16.... 39-17.... 41-18... 43-19... 45.... 49-1... 50-2...

More information

老人性不整脈

老人性不整脈 資料 : QOL CHADS NOAC はじめに common disease 高齢者の不整脈の頻度, AF AVB RBBB LBBB Cardiovascular Health Study, 137 表 1 Outpatient Atarashi Cardiovascular Health Study Monolio No F M Ectopic beats Supraventricular.

More information

i

i 14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7

More information

食道がん化学放射線療法後のsalvage手術

食道がん化学放射線療法後のsalvage手術 2006 2 17 52 Daly JM, et al. J Am Coll Surg 2000;190:562-573 Esophageal Cancer: Results of an American College of Surgeons Patient Care Evaluation Study Daly JM, et al. J Am Coll Surg 2000;190:562-573

More information

第1部 一般的コメント

第1部 一般的コメント (( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12

More information

Upper limit of reference value of QT interval for rest electrocardiograms Hiroshi Goto, Noriaki Ikeda, Masuo Shirataka, Hideo Miyahara of healthy young Japanese men 13) Efron B, Tibshirani, RJ

More information

第1章 国民年金における無年金

第1章 国民年金における無年金 1 2 3 4 ILO ILO 5 i ii 6 7 8 9 10 ( ) 3 2 ( ) 3 2 2 2 11 20 60 12 1 2 3 4 5 6 7 8 9 10 11 12 13 13 14 15 16 17 14 15 8 16 2003 1 17 18 iii 19 iv 20 21 22 23 24 25 ,,, 26 27 28 29 30 (1) (2) (3) 31 1 20

More information

Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination

Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination Fig. 1 The value of fungal index and D- arabinitol/creatinine. Fungal index was mesured by Endotoxin D and Endospecy

More information

技能継承に関するアンケートの結果概要

技能継承に関するアンケートの結果概要 I 1 1 1 1 1 1 2 1 3 1 II 2 1 2 2 2 3 2007 2 4 3 III 4 1 4 4 5 6 2 7 7 8 9 3 10 _10 11 _12 _13 _14 15 4 2007 16 2007 16 17 2007 18 5 19 19 I 2007 1 2005 6 21 8 3 3000 2 292 292 9.7 3 100 1 II 1 86 2 OJT

More information

2.R R R R Pan-Tompkins(PT) [8] R 2 SQRS[9] PT Q R WQRS[10] Quad Level Vector(QLV)[11] QRS R Continuous Wavelet Transform(CWT)[12] Mexican hat 4

2.R R R R Pan-Tompkins(PT) [8] R 2 SQRS[9] PT Q R WQRS[10] Quad Level Vector(QLV)[11] QRS R Continuous Wavelet Transform(CWT)[12] Mexican hat 4 G-002 R Database and R-Wave Detecting System for Utilizing ECG Data Takeshi Nagatomo Ikuko Shimizu Takeshi Ikeda Akio Sashima Koichi Kurumatani R R MIT-BIH R 90% 1. R R [1] 2 24 16 Tokyo University of

More information

I PD-I-3 VA ICD 2006 NYHA ~ LVEF 35% a ICD SCD-HeFT ICD MADIT- ICD a CABG-Patch ICD EF b MADITø MADIT- MUSTT EPS EPS 19 EPS 5/19 VA PD-I-4 Holter LP f

I PD-I-3 VA ICD 2006 NYHA ~ LVEF 35% a ICD SCD-HeFT ICD MADIT- ICD a CABG-Patch ICD EF b MADITø MADIT- MUSTT EPS EPS 19 EPS 5/19 VA PD-I-4 Holter LP f J Arrhythmia Vol 23 (Suppl) 2007 PD-I-1 OACIS 95% 6.4 (1.5 27.8 4.3 (1.0 18.5), 0.2 (0.05 0.93), respectively MADIT LVEF 30% 192 2.0 12.4% 24 3.1% MADIT 12.1% p=.001), ICD direct PCI OACIS (Osaka Acute

More information

9) Rankin, A. C., Rae, A. P., Oldroyd, K. G., et al.: Adenosine or adenosine triphosphate for supraventricular tachycardia? Circulation 78 (Suppl II): 500,1988. 10) Motte, G., Waynberger, M., Lebars, A.,

More information